Merck Manual

Please confirm that you are a health care professional

honeypot link

Overview of Drug Treatment in Children

By

Bridgette L. Jones

, MD, MS, University of Missouri, Kansas City, School of Medicine, Children's Mercy, Kansas City, MO

Last full review/revision Oct 2020| Content last modified Oct 2020
Click here for Patient Education
Topic Resources

Drug treatment in children differs from that in adults, most obviously because pediatric drug dosing is usually based on weight or surface area (1 General references Drug treatment in children differs from that in adults, most obviously because pediatric drug dosing is usually based on weight or surface area (1). Doses (and dosing intervals) differ because... read more ). Doses (and dosing intervals) differ because of age-related variations in drug absorption, distribution, metabolism, and elimination (see Pharmacokinetics in Children Pharmacokinetics in Children Pharmacokinetics refers to the processes of drug absorption, distribution, metabolism, and elimination. There are important age-related variations in pharmacokinetics. Absorption from the gastrointestinal... read more ). Thus, children are not given adult doses. Furthermore, it cannot be assumed that a child’s dose is proportional to an adult’s dose (ie, that a 7-kg child requires 1/10 the dose of a 70-kg adult).

Most drugs have not been adequately studied in children, but federal legislation (the Best Pharmaceuticals for Children Act of 2001 and the Pediatric Research Equity Act of 2003, both made permanent in 2012—2 General references Drug treatment in children differs from that in adults, most obviously because pediatric drug dosing is usually based on weight or surface area (1). Doses (and dosing intervals) differ because... read more ; see also the U.S. Food and Drug Administration [FDA] 2016 status report) now provides the statutory and regulatory authority to incentivize and require therapeutic trials in children. As a result of this legislation, numerous labeling changes were made to provide dosing, pharmacokinetic, and safety information for children.

General references

  • 1. Le J, Bradley JS: Optimizing antibiotic drug therapy in pediatrics: Current state and future needs. J Clin Pharmacol 58 (supplement 10):S108–S122, 2018. doi: 10.1002/jcph.1128

  • 2. Connor EM, Smoyer WE, Davis JM, et al: Meeting the demand for pediatric clinical trials. Sci Transl Med 6(227):227fs11, 2014. doi: 10.1126/scitranslmed.3008043

Adverse effects and toxicity

Children are generally subject to the same adverse effects as adults (see Adverse Drug Reactions Adverse Drug Reactions read more ), but they have increased risk with certain drugs because of differences in pharmacokinetics or because of drug effects on growth and development. Some common drugs with unique or higher risk of adverse effects in children are listed in table Drugs Manifesting Differential Toxicity in Children Drugs Manifesting Differing Toxicity in Children Drug treatment in children differs from that in adults, most obviously because pediatric drug dosing is usually based on weight or surface area (1). Doses (and dosing intervals) differ because... read more .

Table
icon

Younger children are at especially high risk of accidental poisoning when they discover and take caregivers’ vitamins or drugs, even vitamins and drugs that have been thrown away. When discarding a drug, consumers may seek disposal instructions on the package insert or review information at the Food and Drug Administration's web site). Options include taking the drug to a local drug collection program (possibly at a pharmacy or local law enforcement site) or mixing the drug with an undesirable material (eg, cat litter, coffee grounds), tightly wrapping it in plastic, placing it in a watertight container or bag, and disposing it in the trash.

Other types of inadvertent exposure include skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for motion sickness, malathion for lice, diphenhydramine for poison ivy).

Adverse effects, including death, have occurred in children receiving over-the-counter cough and cold preparations containing some combination of an antihistamine, sympathomimetic decongestant, and the antitussive dextromethorphan. Current recommendations are that such products should not be given to children < 4 years.

Adverse effects and toxicity reference

More Information

The following are some English-language resources that may be useful. Please note that THE MANUAL is not responsible for the content of these resources.

Drugs Mentioned In This Article

Drug Name Select Trade
DELSYM
COMPRO
No US trade name
ACHROMYCIN V
ROCEPHIN
TRANSDERM SCOP
ANBESOL
XYLOCAINE
DURAMORPH PF, MS CONTIN
No US brand names
No US brand name
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

OTHER TOPICS IN THIS CHAPTER

Professionals also read

Test your knowledge

Congenital Limb Abnormalities
Congenital limb amputations and deficiencies are missing or incomplete limbs at birth. There are many possible causes of congenital limb amputations, and they often occur as a component of various congenital syndromes. Which of the following causes of these amputations is most common?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
TOP